8 Einträge gefunden

1. Acceptance and Benefits of Two Different Strategies to Timely Integrate Specialist Palliative Care into Routine Cancer Care - a Randomized Pilot Study

   1. Ullrich, Anneke
   2. Wilde, Svenja
   3. Müller, Volkmar
   4. Sinn, Marianne
   5. Gebhardt, Christoffer
   6. Velthaus, Janna-Lisa
   7. Gerlach, Christina

   2022 - Forschungsinformationssystem des UKE
2. Use of Process Modelling for Optimization of Molecular Tumor Boards

   1. Lauk, Katharina
   2. Peters, Mia-Carlotta
   3. Velthaus, Janna-Lisa
   4. Nürnberg, Sylvia
   5. Ueckert, Frank

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Lorlatinib Induces Durable Disease Stabilization in a Pancreatic Cancer Patient with a ROS1 p.L1950F Mutation: Case Report

   1. Velthaus, Janna-Lisa
   2. Iglauer, Peter
   3. Simon, Ronald
   4. Bokemeyer, Carsten
   5. Bannas, Peter
   6. Beumer, Niklas
   7. Imbusch, Charles D

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors

   1. Janning, Melanie
   2. Kobus, Franca
   3. Babayan, Anna
   4. Wikman, Harriet
   5. Velthaus, Janna-Lisa
   6. Bergmann, Sonja
   7. Schatz, Stefanie

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
5. Die medikamentöse onkologische Therapie im Wandel - Aufbau von Strukturen zur Patientenversorgung

   1. Velthaus, Janna-Lisa
   2. Bokemeyer, Carsten
   3. Loges, Sonja

   2018 - Forschungsinformationssystem des UKE
6. Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease

   1. Hanssen, Annkathrin
   2. Riebensahm, Carlotta
   3. Mohme, Malte
   4. Joosse, Simon A
   5. Velthaus, Janna-Lisa
   6. Berger, Lars Arne
   7. Bernreuther, Christian

   2018 - Forschungsinformationssystem des UKE - frei zugänglich
7. Identification of a High-Level MET Amplification in CTCs and cfTNA of an ALK-Positive NSCLC Patient Developing Evasive Resistance to Crizotinib

   1. Berger, Lars-Arne
   2. Janning, Melanie
   3. Velthaus, Janna-Lisa
   4. Ben-Batalla, Isabel
   5. Schatz, Stefanie
   6. Falk, Markus
   7. Iglauer, Peter

   2018 - Forschungsinformationssystem des UKE
8. Maligne periphere Nervenscheidentumoren bei Neurofibromatose Typ 1 : Angiogeneseprofil, Malignant peripheral nerve sheath tumors in Neurofibromatosis Type 1 : Angiogenetic profile

   1. Velthaus, Janna-Lisa

   2016 - E-Dissertationen der UHH - frei zugänglich